🇺🇸 FDA
Pipeline program

phacoemulsification

2

Approved other active

Quick answer

phacoemulsification for Astigmatism is a Approved program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Astigmatism
Phase
Approved
Modality
other
Status
active

Clinical trials